Location · Hackensack, NJ
Clinical trials in Hackensack, NJ
35 recruiting studies have a site in Hackensack, and 7 of them accept healthy volunteers.
35 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1/Phase 2
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
Hackensack Meridian Health
- Location
- Hackensack, NJ
- Eligibility basics
- Ages 50+ · Men only
- RecruitingHealthy volunteersPhase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Pfizer
- Location
- Hackensack, NJ + 138 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Peerbridge Health, Inc
- Location
- Hackensack, NJ + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
- Location
- Hackensack, NJ + 70 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Rapport Therapeutics Inc.
- Location
- Hackensack, NJ + 13 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
The HEARTFELT Study
Heartfelt Technologies
- Location
- Hackensack, NJ + 1 other US site
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Sanofi
- Location
- Hackensack, NJ + 9 other US sites
- Eligibility basics
- Ages 1–11 · Men only
- RecruitingPhase 3
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
SymBio Pharmaceuticals
- Location
- Hackensack, NJ + 24 other US sites
- Eligibility basics
- Ages 2 mo+
- RecruitingPhase 2
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy
Actio Biosciences, Inc.
- Location
- Hackensack, NJ
- Eligibility basics
- Ages 1 mo–21
- RecruitingPhase 3
A Gaucher Disease Gene Therapy Trial With FLT201
Spur Therapeutics
- Location
- Hackensack, NJ + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Incyte Corporation
- Location
- Hackensack, NJ + 36 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
- Location
- Hackensack, NJ + 44 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Xenon Pharmaceuticals Inc.
- Location
- Hackensack, NJ + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Hoffmann-La Roche
- Location
- Hackensack, NJ + 8 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 1/Phase 2
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Sumitomo Pharma America, Inc.
- Location
- Hackensack, NJ + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Supernus Pharmaceuticals, Inc.
- Location
- Hackensack, NJ + 36 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Shockwave Medical, Inc.
- Location
- Hackensack, NJ + 66 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
CorMedix Therapeutics
- Location
- Hackensack, NJ + 5 other US sites
- Eligibility basics
- Up to age 17
- Recruiting
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
Herrick Medical LLC
- Location
- Hackensack, NJ
- Eligibility basics
- Ages 50–100
- Recruiting
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion
- Location
- Hackensack, NJ + 31 other US sites
- Eligibility basics
- Ages 21+
- RecruitingPhase 1/Phase 2
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
- Location
- Hackensack, NJ + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nkarta, Inc.
- Location
- Hackensack, NJ + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
ViiV Healthcare
- Location
- Hackensack, NJ + 32 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN Therapeutics, Inc.
- Location
- Hackensack, NJ + 15 other US sites
- Eligibility basics
- Ages 1 mo–18